These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Mucosal healing and anti TNFs in IBD. van Assche G; Vermeire S; Rutgeerts P Curr Drug Targets; 2010 Feb; 11(2):227-33. PubMed ID: 20210770 [TBL] [Abstract][Full Text] [Related]
8. [Crohn's disease--infliximab, adalimumab and certolizumab-pegol: clinical value of anti-TNF-alpha treatment]. Schreiber S Dtsch Med Wochenschr; 2007 Aug; 132(34-35):1770-4. PubMed ID: 17713889 [TBL] [Abstract][Full Text] [Related]
9. Recommendations for the treatment of Crohn's disease with tumor necrosis factor antagonists: an expert consensus report. Feagan BG; Lémann M; Befrits R; Connell W; D'Haens G; Ghosh S; Michetti P; Ochsenkühn T; Panaccione R; Schreiber S; Silverberg M; Sorrentino D; van der Woude CJ; Vermeire S; Rutgeerts P Inflamm Bowel Dis; 2012 Jan; 18(1):152-60. PubMed ID: 22038857 [TBL] [Abstract][Full Text] [Related]
11. [Effectiveness of anti-TNF alpha antibodies in treatment of fistulizing Crohn's disease]. Rozpondek P; Zwolińska-Wcisło M; Przybylska M; Mach T Przegl Lek; 2011; 68(9):602-5. PubMed ID: 22335009 [TBL] [Abstract][Full Text] [Related]
12. How future tumor necrosis factor antagonists and other compounds will meet the remaining challenges in Crohn's disease. Sandborn WJ Rev Gastroenterol Disord; 2004; 4 Suppl 3():S25-33. PubMed ID: 15583528 [TBL] [Abstract][Full Text] [Related]
13. Review article: the efficacy of infliximab in Crohn's disease--healing of fistulae. Present DH Aliment Pharmacol Ther; 1999 Sep; 13 Suppl 4():23-8; discussion 38. PubMed ID: 10597336 [TBL] [Abstract][Full Text] [Related]
14. Optimizing anti-TNF treatment in inflammatory bowel disease. Rutgeerts P; Van Assche G; Vermeire S Gastroenterology; 2004 May; 126(6):1593-610. PubMed ID: 15168370 [TBL] [Abstract][Full Text] [Related]
15. Anti-TNF and fistulizing perianal Crohn's disease: use in clinical practice. Bourikas LA; Koutroubakis IE Curr Drug Targets; 2010 Feb; 11(2):187-97. PubMed ID: 19916954 [TBL] [Abstract][Full Text] [Related]
16. Concomitant therapy with methotrexate and anti-TNF-α in pediatric patients with refractory crohn's colitis: a case series. Absah I; Faubion WA Inflamm Bowel Dis; 2012 Aug; 18(8):1488-92. PubMed ID: 21882301 [TBL] [Abstract][Full Text] [Related]
17. Maintenance of remission in Crohn's disease: current and emerging therapeutic options. Brookes MJ; Green JR Drugs; 2004; 64(10):1069-89. PubMed ID: 15139787 [TBL] [Abstract][Full Text] [Related]
18. Anti-tumor necrosis factor agents reduce corticosteroid use compared with azathioprine in patients with Crohn's disease. Kane SV; Jaganathan S; Bedenbaugh AV; Palmer L; Schwartz DA Curr Med Res Opin; 2014 Sep; 30(9):1821-6. PubMed ID: 24884302 [TBL] [Abstract][Full Text] [Related]